Uncategorized: Topic Summary Hub
🔍 CED Perspective Lens: Uncategorized
Dr. Benjamin Caplan, MD
Uncategorized represents a fundamental pillar in medical endocannabinoid therapy. Every guide in this hub synthesizes peer-reviewed evidence, clinical dosing strategies, and physiological mechanism maps curated specifically for patient care and clinical guidance.
📚 Clinical Resources & Guides (50 Full Guides)
Raleigh Felon Sentenced to Federal Prison for Possessing a Firearm
[#item_full_content] Read More Google Alert – “marijuana”…
# Does Marijuana Help Erectile Dysfunction? *gNkBEBSx1* – FC Bayern
[#item_full_content] Read More Google Alert – “marijuana”…
Cannabinoids in Autism Spectrum Disorder Treatment: Safety and Effectiveness Evidence
Clinical Takeaway Research suggests that CBD-based treatments, particularly combined CBD and THC formulations, may reduce certain behavioral symptoms in children and adolescen…
Cannabis Dosing in Family Medicine: Clinical Research and Evidence-Based Care Strategies for Endocannabinoid System Optimization
Clinical Takeaway GLP-1 receptor agonists, commonly known as medications like semaglutide, were studied using genetic methods to assess their causal effect on ten major psychi…
Cannabidiol’s Impact on Social Skills Anxiety & Parental Stress in Autistic Children: Evidence from a Randomized Controlled Clinical Trial
Clinical Takeaway In a randomized, double-blind, placebo-controlled crossover trial of 29 autistic children aged 5 to 12, oral CBD oil dosed at 10 mg/kg/day was evaluated over…
Endocannabinoid System Clinical Research: Evidence-Based Cannabis Care for At-Risk Adolescents
Clinical Takeaway Tailored cannabis prevention messaging that first addresses and rebukes a teen’s negative reaction to an initial warning may be more effective than single-me…
Cannabis Clinical Trials: Evidence-Based Cannabis Dosing in Family Medicine
Clinical Takeaway A digital therapeutic tailored specifically for people living with HIV showed feasibility and acceptability as a smoking cessation tool, addressing a populat…
Cannabidiol Interactions with Prescription Medications: A Review of Clinical Evidence
Clinical Takeaway CBD can interact with other medications, particularly opioids and drugs processed by the same liver enzymes, which matters most for cancer patients already t…
Endocannabinoid System Research: Cannabis Dosing Strategies in Family Medicine
Clinical Takeaway A smartphone-based AI relational agent (Woebot for Substance Use Disorders) was tested in a randomized controlled trial against a psychoeducational comparato…
Maternal Cannabis Use & Autism/ADHD Risk: A Review of Endocannabinoid System Research
Clinical Takeaway Children born to mothers who used cannabis during pregnancy showed a modest increase in risk for autism spectrum disorder and a smaller increase in risk for …
Endocannabinoid System Research: Cannabis Evidence-Based Care for Autism Spectrum Disorder
Clinical Takeaway Cannabinoid-based treatments, including CBD-rich preparations, have shown promising early results for reducing certain behavioral symptoms in autism spectrum…
Cannabis Use in Adolescents: Exploring Endocannabinoid System’s Role in Anxiety & Depression
Clinical Takeaway Adolescents with depression and anxiety symptoms showed increased likelihood of initiating and using cannabis more frequently over an 18-month follow-up peri…
Cannabis Use Trauma Survivors Endocannabinoid System Insomnia Treatment
Clinical Takeaway Insomnia symptoms present before a traumatic event may increase the risk of alcohol and cannabis use in the weeks and months following trauma exposure. Clini…
Cannabidiol’s Impact on Cortical Excitability: Evidence from a Randomized Double-Blind Study
Clinical Takeaway In this rigorous crossover trial, neither a low nor a high single dose of CBD directly altered cortical excitability or produced measurable sedation in healt…
Cannabis Dosing in Family Medicine: Endocannabinoid System Clinical Research on 1:1 THC:CBD Oil for Fibromyalgia Symptoms
Clinical Takeaway In a small, double-blind, placebo-controlled pilot trial of 24 adults with fibromyalgia, a 1:1 THC:CBD cannabis oil was found to be feasible and generally we…
Cannabis Medicine vs Placebo for Fibromyalgia: A Randomized Clinical Trial
Clinical Takeaway In this randomized, double-blind, placebo-controlled trial, CBD did not demonstrate superiority over placebo in reducing pain among patients with fibromyalgi…
Cannabis in Family Medicine: Evidence-Based Dosing Strategies for Endocannabinoid System Support
Clinical Takeaway Cannabis was the most commonly used recreational drug among youth presenting to emergency departments with acute behavioral disturbance, reported by 25% of p…
AI Review: The Cannabis Handbook
AI just reviewed my book, The Doctor-Approved Cannabis Handbook, and it’s a must-see! In under 8 minutes, they cover cannabis science, debunk myths, and share patient stories—…
Potential Risks and Side Effects of Medical Cannabis
Comprehensive clinical evidence review and medical guidance on potential risks and side effects of medical cannabis….
Exploring the Therapeutic Potential of Minor Cannabinoids in Dermatology: From Psoriasis to Acne
Introduction Emerging research in dermatology indicates that lesser-known cannabinoids, such as THCV, CBDV, CBC, CBM, and CBN, may offer therapeutic benefits for various skin …
Arizona Saw Marijuana Sales Start To Slip, Hitting Lowest Numbers In Almost A Year
May’s total was the lowest since September 2022, when the state reported sales at $80.9 million. By David Abbott, Arizona Mirror Arizona’s marijuana market trended downward in…
How To Wind Up a Cannabis Company
By Vince Sliwoski, Attorney at Harris Bricken Most cannabis companies are not wound up properly, some cannabis companies (and their owners) suffer repercussions for this, and …
Do Cannabis Farms Count as Agriculture? The Answer Could Cost Michigan Schools.
The state’s funding sources for education come from a variety of places, including sales tax, use tax, tobacco taxes and the lottery. But agricultural properties in the state …
Chicago Cannabis Fintech Claims FIS Killed Its Company
Chicago-based cannabis financial technology company Spence Labs is suing tech biggie Fidelity National Information Services (FIS) (NYSE: FIS) claiming the company backed out o…
Alabama Judge Rejects Medical Marijuana Officials’ Request To Delay Lawsuit So They Can Award Licenses A Third Time
“We just want to reverse course, put things on a better track so that it avoids the problems.” By Alander Rocha, Alabama Reflector A Montgomery County Circuit Judge Thursday d…
Former Trump Drug Czar Says Top Federal Officials Stopped FDA From Scheduling Kratom Amid Concern About Agency’s ‘Bias’
As the U.S. Food and Drug Administration (FDA) under the Trump administration prepared to propose federal restrictions on kratom, a number of top officials intervened, critici…
Green Market Report Finance Awards: Top Investment Firm Entourage Effect Capital
On August 3, Green Market Report hosted its 2023 Finance Summit. At the Summit, the winners of the 2023 GMR Cannabis Finance Awards were announced. The winner of the Top Inves…
The First Republican Primary Debate Sucked for Everyone Except Trump
Each of the eight participants in the first 2024 Republican primary debates went to Milwaukee knowing they had to make an impact. It’s likely that they imagined this would be …
Only One In 10 Ohio Prosecutors Say They’ll Seal Drug Records Under Reform Law, With Most Eyeing Relief For Marijuana Convictions, Study Finds
As Ohio voters prepare to decide on a marijuana legalization initiative on the November ballot, only about one in 10 Ohio prosecutors say they’re likely to take advantage of a…
Ohio Officials Approve Ballot Language For Marijuana Legalization Initiative That Will Go Before Voters In November
Ohio officials have unanimously approved ballot language for an initiative to legalize marijuana that will appear before voters on the November election. At a hearing on Thurs…
Big Plan Holdings Buys PA Retail Spot from Ascend for $3.25M
The family office operates at the intersection of music, fashion, and sports, which it said includes the cannabis industry. Big Plan Holdings teamed up with Evelyn Capital to …
Incannex Seeks FDA Approval for Psilocybin-Assisted Psychotherapy Program
An independent review supported earlier positive findings. Clinical-stage pharmaceutical Incannex Healthcare Ltd. (Nasdaq: IXHL) is moving forward with a new psychotherapy tre…
High Times Names 5th CEO in 5 Years
Despite a looming deadline with its lender ExWorks, High Times named Shaun Jarvis as interim chief executive officer. The financially troubled cannabis media company saw the d…
Another New Jersey Police Officer Fired Over Marijuana Must Be Reinstated, Judge Rules
A New Jersey administrative law judge has dealt another blow to Jersey City’s police chief and mayor, ordering the reinstatement of another officer who was fired after testing…
New Jersey Cannabis Industry in ‘Doom Loop,’ Trade Group Says
Red tape, illicit market competition, and a lack of enforcement by regulators have all created a “doom loop” for licensed cannabis companies in New Jersey, one of the state’s …
Audit: Michigan Cannabis Regulatory Agency effective, should speed up disciplinary actions
When Michigan Gov. Gretchen Whitmer named Brian Hanna as the acting executive director of the state’s Cannabis Regulatory Agency nearly a year ago (he later was named the exec…
The Daily Hit: August 24, 2023
The Daily Hit is a recap of the top financial news stories for Aug. 24, 2023. On The Site High Times Names Fifth CEO in 5 Years Despite a looming deadline with its lender ExWo…
POSaBIT Records $1.8M Loss Despite Spike in Revenue
Cannabis payment provider POSaBIT Systems Corp. (CSE: PBIT) (OTC: POSAF) posted a $1.8 million loss for the second quarter of 2023, despite increasing its revenue by 64% year-…
Congressional Research Service Notes Hemp Industry’s Recent Decline Amid FDA Inaction On CBD Rules
A new report from the Congressional Research Service (CRS) offers an overview of challenges facing the nation’s hemp industry as lawmakers work to craft a regulatory framework…
North Carolina Medical Marijuana Commission That Doesn’t Even Exist Yet Has Its First Member Amid Legalization Bill’s Stalling
A North Carolina official has now been appointed to serve on a medical cannabis commission that doesn’t even formally exist yet under state law. The problem is, the medical ma…
TGOD Merger Boosts BZAM Q2 Revenues Amid Losses
BZAM Ltd. (OTC: BZAMF) reported its financial results ending June 30, showing rises in revenue but much higher losses. The company saw an 89% increase in gross revenues versus…
Vermont Continues to Deliver Revenue for Slang
SLANG Worldwide Inc. (CNSX: SLNG) (OTCQB: SLGWF) reported revenue for the three months ended June 30 fell to $8.44 million versus last year’s $9.87 million for the same time p…
GOP Congressman Pushes DEA Head For Update On Biden’s Marijuana Scheduling Review
A GOP congressman is pressing the head of the Drug Enforcement Administration (DEA) to expand on her recent remarks about the origin and timeline of President Joe Biden’s mari…
Allen Iverson’s cannabis strains to be sold at medical marijuana dispensaries in Pennsylvania
Allen Iverson’s impact on the game of basketball is well-documented, and the former NBA MVP is still lauded as one of the most influential players 13 years after his last… The…
NYC Could See $1.2 Billion In Marijuana Sales Annually, But Licensing Hiccups And Unregulated Market Are Holding It Back, City Economists Say
New York City could eventually see marijuana sales reach up to $1.2 billion annually, resulting in about $47 million in local tax revenue, a new report from a government-funde…
Patients Say Marijuana Treats Neuropathy Just As Well As Opioids, And Most Report Using High-THC Cannabis, New Survey Finds
Marijuana is just as effective at treating symptoms of neuropathy as opioids are, according to the results of a new survey. And what’s more, the majority of patients with the …
State Audit Finds Michigan’s Marijuana Regulators Are Falling Behind On Disciplinary Action For Business Violations
The audit found CRA didn’t complete disciplinary action for “555 formal complaints with violations that, as of September 30, 2022, had been open an average of 529 days.” By Sc…
Marijuana Farmers Market Opens Alongside New York State Fair
The New York State Fair kicked off on Wednesday, and for the first time ever, attendees have the chance to browse—and buy—marijuana products from nearly a dozen local growers …
The Daily Hit: August 23, 2023
The Daily Hit is a recap of the top financial news stories for Aug. 23, 2023. On the Site New York Regulators Name 30 Dispensaries Eligible to Open Under Court Order Only 30 c…
Missouri Cannabis Regulators Crack Down on ‘Lab Shopping’
The demand for potent cannabis products has put labs under pressure to guarantee high THC levels, and now Missouri’s state health department is stepping up to ensure standardi…